e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Airway cells as targets for anti-inflammatory drugs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD
B. Grensemann, B. Sibbing, D. Jungck, K. Urban, E. Stoelben, J. Strauch, J. Knobloch, A. Koch (Cologne, Germany)
Source:
Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Session:
Airway cells as targets for anti-inflammatory drugs
Session type:
Oral Presentation
Number:
2123
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Grensemann, B. Sibbing, D. Jungck, K. Urban, E. Stoelben, J. Strauch, J. Knobloch, A. Koch (Cologne, Germany). Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD. Eur Respir J 2010; 36: Suppl. 54, 2123
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Synthetic airway smooth muscle cells regulate airway inflammation
Source: Annual Congress 2010 - Airway smooth muscle cells: multifunctional cells in asthma pathogenesis
Year: 2010
Resveratrol is superior to dexamethasone in suppressing cytokine release from human airway smooth muscle cells exposed to lipoteichoic acid in COPD
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion
Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018
Year: 2018
Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002
Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004
Transcriptional regulation of CXCL8 hypersecretion in asthmatic airway smooth muscle cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Increased STIM1 expression induced by cigarette smoking extracts regulates the proliferation and production of inflammatory cytokines in human airway smooth muscle cells
Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology
Year: 2020
IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012
The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006
Effect of cigarette smoke extract on inflammatory cytokine and chemokine production in human airway smooth muscle cells
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Effect of cigarette smoke extract and Th17 cytokine on production of inflammatory cytokines and chemokines in human airway smooth muscle cells
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept